igforum.bio / 6-questions-about-hr-positive-her2-negative-metastatic-breast-cancer-answered-everyday-health - 158265
L
%  6 Questions About HR-Positive/HER2-Negative Metastatic Breast Cancer — Answered  Everyday Health MenuNewslettersSearch Breast Cancer
 6 Questions About HR-Positive HER-2-Negative Metastatic Breast Cancer Answered
Being diagnosed with stage 4 breast cancer is certainly scary, but the situation is far from hopeless. Arm yourself with information by checking out the answers to these questions. By Julia CalifanoMedically Reviewed by Krystal Cascetta, MDReviewed: March 18, 2021Medically ReviewedLearn more about stage 4 breast cancer to gain a better understanding of your diagnosis.Phil Fisk/Getty ImagesMetastatic is generally not a word you want to hear from your oncologist.
%  6 Questions About HR-Positive/HER2-Negative Metastatic Breast Cancer — Answered Everyday Health MenuNewslettersSearch Breast Cancer 6 Questions About HR-Positive HER-2-Negative Metastatic Breast Cancer Answered Being diagnosed with stage 4 breast cancer is certainly scary, but the situation is far from hopeless. Arm yourself with information by checking out the answers to these questions. By Julia CalifanoMedically Reviewed by Krystal Cascetta, MDReviewed: March 18, 2021Medically ReviewedLearn more about stage 4 breast cancer to gain a better understanding of your diagnosis.Phil Fisk/Getty ImagesMetastatic is generally not a word you want to hear from your oncologist.
thumb_up Like (37)
comment Reply (2)
share Share
visibility 359 views
thumb_up 37 likes
comment 2 replies
J
Jack Thompson 4 minutes ago
But a diagnosis of hormone receptor–positive (HR-positive)/human epidermal growth factor receptor ...
I
Isabella Johnson 3 minutes ago
And new therapies are helping patients live longer than ever before. To help you regain a sense of c...
T
But a diagnosis of hormone receptor–positive (HR-positive)/human epidermal growth factor receptor 2–negative (HER-2-negative) metastatic breast cancer may not be as dire as you’d imagine. While it means that your cancer has spread from the original tumor to other parts of your body, this subtype of invasive breast cancer tends to grow slowly and be less aggressive than other subtypes, according to Adam Brufsky, MD, PhD, codirector of the Comprehensive Breast Cancer Center at the University of Pittsburgh.
But a diagnosis of hormone receptor–positive (HR-positive)/human epidermal growth factor receptor 2–negative (HER-2-negative) metastatic breast cancer may not be as dire as you’d imagine. While it means that your cancer has spread from the original tumor to other parts of your body, this subtype of invasive breast cancer tends to grow slowly and be less aggressive than other subtypes, according to Adam Brufsky, MD, PhD, codirector of the Comprehensive Breast Cancer Center at the University of Pittsburgh.
thumb_up Like (1)
comment Reply (0)
thumb_up 1 likes
L
And new therapies are helping patients live longer than ever before. To help you regain a sense of control over your health and make the treatment decisions that are best for you, we gathered answers to some of the most pressing questions people have about HR-positive/HER-2-negative metastatic breast cancer.
And new therapies are helping patients live longer than ever before. To help you regain a sense of control over your health and make the treatment decisions that are best for you, we gathered answers to some of the most pressing questions people have about HR-positive/HER-2-negative metastatic breast cancer.
thumb_up Like (20)
comment Reply (2)
thumb_up 20 likes
comment 2 replies
H
Hannah Kim 12 minutes ago
1 What does HR-positive HER-2-negative mean Although breast cancer is often thought of as one dis...
D
Daniel Kumar 4 minutes ago
It also means your treatment can include drugs designed to affect hormone production. Roughly two ou...
E
1  What does HR-positive HER-2-negative mean 
Although breast cancer is often thought of as one disease, there are more than 20 subtypes that differ in presentation, response to treatment, and outcomes, according to the American Cancer Society (ACS). A breast cancer is classified as HR-positive if its cells have receptors for the hormones estrogen and progesterone, which suggests the cancer cells receive signals from these hormones that promote their growth.
1 What does HR-positive HER-2-negative mean Although breast cancer is often thought of as one disease, there are more than 20 subtypes that differ in presentation, response to treatment, and outcomes, according to the American Cancer Society (ACS). A breast cancer is classified as HR-positive if its cells have receptors for the hormones estrogen and progesterone, which suggests the cancer cells receive signals from these hormones that promote their growth.
thumb_up Like (21)
comment Reply (3)
thumb_up 21 likes
comment 3 replies
B
Brandon Kumar 8 minutes ago
It also means your treatment can include drugs designed to affect hormone production. Roughly two ou...
E
Evelyn Zhang 14 minutes ago
Cancer tissue is also tested for HER-2 proteins, or receptors, that help control the growth and repa...
J
It also means your treatment can include drugs designed to affect hormone production. Roughly two out of three breast cancers test positive for hormone receptors, the ACS says.
It also means your treatment can include drugs designed to affect hormone production. Roughly two out of three breast cancers test positive for hormone receptors, the ACS says.
thumb_up Like (12)
comment Reply (3)
thumb_up 12 likes
comment 3 replies
M
Mia Anderson 15 minutes ago
Cancer tissue is also tested for HER-2 proteins, or receptors, that help control the growth and repa...
J
Julia Zhang 12 minutes ago
Brufsky. A HER-2-negative diagnosis also means your cancer won’t benefit from therapies that targe...
L
Cancer tissue is also tested for HER-2 proteins, or receptors, that help control the growth and repair of breast cells. An overexpression of HER-2 proteins causes a marked increase in the reproduction of breast cells, a situation referred to as HER-2-positive. HER-2-negative breast cancers, on the other hand, have cells that contain little to no HER-2 protein, so they tend to grow more slowly and have a better outlook than HER-2-positive cancers, explains Dr.
Cancer tissue is also tested for HER-2 proteins, or receptors, that help control the growth and repair of breast cells. An overexpression of HER-2 proteins causes a marked increase in the reproduction of breast cells, a situation referred to as HER-2-positive. HER-2-negative breast cancers, on the other hand, have cells that contain little to no HER-2 protein, so they tend to grow more slowly and have a better outlook than HER-2-positive cancers, explains Dr.
thumb_up Like (2)
comment Reply (1)
thumb_up 2 likes
comment 1 replies
T
Thomas Anderson 4 minutes ago
Brufsky. A HER-2-negative diagnosis also means your cancer won’t benefit from therapies that targe...
E
Brufsky. A HER-2-negative diagnosis also means your cancer won’t benefit from therapies that target the HER-2 protein. “Roughly half of metastatic breast cancers are both HR-positive and HER-2-negative,” says Brufsky.
Brufsky. A HER-2-negative diagnosis also means your cancer won’t benefit from therapies that target the HER-2 protein. “Roughly half of metastatic breast cancers are both HR-positive and HER-2-negative,” says Brufsky.
thumb_up Like (49)
comment Reply (1)
thumb_up 49 likes
comment 1 replies
E
Evelyn Zhang 5 minutes ago
“About 70 percent of the time, this subtype of breast cancer spreads to the bone. It’s also comm...
H
“About 70 percent of the time, this subtype of breast cancer spreads to the bone. It’s also commonly found in soft tissue like lymph nodes. It’s sometimes seen in organs like the lungs or liver, and it’s occasionally found in skin.”

 What My Mom s Metastatic Breast Cancer Means to MeLisa never hid her breast cancer diagnosis from her children.
“About 70 percent of the time, this subtype of breast cancer spreads to the bone. It’s also commonly found in soft tissue like lymph nodes. It’s sometimes seen in organs like the lungs or liver, and it’s occasionally found in skin.” What My Mom s Metastatic Breast Cancer Means to MeLisa never hid her breast cancer diagnosis from her children.
thumb_up Like (11)
comment Reply (1)
thumb_up 11 likes
comment 1 replies
S
Sofia Garcia 8 minutes ago
As a result, her daughter learned many life lessons.Watch the video 2 How is this cancer treated Y...
J
As a result, her daughter learned many life lessons.Watch the video
 2  How is this cancer treated Your treatment plan will depend on where the cancer has spread, the extent of the disease, other medical conditions you have, and your age and menopause status. Common therapies include:Ovarian suppression For premenopausal women with metastatic breast cancer of this type, hormone therapy almost always begins with ovarian suppression by means of surgery to remove the ovaries (oophorectomy) or drugs, such as goserelin or leuprolide, that stop the ovaries from producing hormones, says Brufsky.
As a result, her daughter learned many life lessons.Watch the video 2 How is this cancer treated Your treatment plan will depend on where the cancer has spread, the extent of the disease, other medical conditions you have, and your age and menopause status. Common therapies include:Ovarian suppression For premenopausal women with metastatic breast cancer of this type, hormone therapy almost always begins with ovarian suppression by means of surgery to remove the ovaries (oophorectomy) or drugs, such as goserelin or leuprolide, that stop the ovaries from producing hormones, says Brufsky.
thumb_up Like (2)
comment Reply (1)
thumb_up 2 likes
comment 1 replies
M
Mia Anderson 2 minutes ago
Ovarian suppression lowers hormone levels in the body so the tumor can’t get the estrogen it needs...
S
Ovarian suppression lowers hormone levels in the body so the tumor can’t get the estrogen it needs to grow.Aromatase inhibitors (AIs) Postmenopausal women — and premenopausal women who have undergone removal or suppression of their ovaries — are often treated with AIs, such as anastrozole, exemestane, and letrozole. These drugs block the activity of the enzyme aromatase, which the body uses to make estrogen in the adrenal glands and fat tissue. This means less estrogen is available to stimulate the growth of HR-positive breast cancer cells, according to the National Cancer Institute.CDK4/6 inhibitors These drugs, which include palbociclib, ribociclib, and abemaciclib, block proteins in the cell known as cyclin-dependent kinases (CDKs).
Ovarian suppression lowers hormone levels in the body so the tumor can’t get the estrogen it needs to grow.Aromatase inhibitors (AIs) Postmenopausal women — and premenopausal women who have undergone removal or suppression of their ovaries — are often treated with AIs, such as anastrozole, exemestane, and letrozole. These drugs block the activity of the enzyme aromatase, which the body uses to make estrogen in the adrenal glands and fat tissue. This means less estrogen is available to stimulate the growth of HR-positive breast cancer cells, according to the National Cancer Institute.CDK4/6 inhibitors These drugs, which include palbociclib, ribociclib, and abemaciclib, block proteins in the cell known as cyclin-dependent kinases (CDKs).
thumb_up Like (16)
comment Reply (1)
thumb_up 16 likes
comment 1 replies
E
Ethan Thomas 1 minutes ago
CDKs regulate cell proliferation and growth and are often elevated in breast cancer, fueling uncontr...
A
CDKs regulate cell proliferation and growth and are often elevated in breast cancer, fueling uncontrolled growth of cancer cells. “They are typically used in combination with AIs as a first-line treatment for HR-positive/HER-2-negative metastatic breast cancer,” Brufsky says. In addition, you may receive treatments that target specific areas of the body that are affected.
CDKs regulate cell proliferation and growth and are often elevated in breast cancer, fueling uncontrolled growth of cancer cells. “They are typically used in combination with AIs as a first-line treatment for HR-positive/HER-2-negative metastatic breast cancer,” Brufsky says. In addition, you may receive treatments that target specific areas of the body that are affected.
thumb_up Like (38)
comment Reply (3)
thumb_up 38 likes
comment 3 replies
J
Joseph Kim 15 minutes ago
Cancer that has spread to the bones, for instance, can be treated with bone-modifying therapy. Chemo...
A
Alexander Wang 22 minutes ago
The most common side effects are menopausal symptoms (such as hot flashes), achiness in the joints a...
E
Cancer that has spread to the bones, for instance, can be treated with bone-modifying therapy. Chemotherapy may also be part of the initial treatment for those struggling with serious symptoms of metastatic breast cancer, such as difficulty breathing. 3  What are the side effects of treatment 
“Generally, the side effects of hormonal therapies tend to be mild and fairly well tolerated,” says Brufsky.
Cancer that has spread to the bones, for instance, can be treated with bone-modifying therapy. Chemotherapy may also be part of the initial treatment for those struggling with serious symptoms of metastatic breast cancer, such as difficulty breathing. 3 What are the side effects of treatment “Generally, the side effects of hormonal therapies tend to be mild and fairly well tolerated,” says Brufsky.
thumb_up Like (46)
comment Reply (3)
thumb_up 46 likes
comment 3 replies
C
Christopher Lee 2 minutes ago
The most common side effects are menopausal symptoms (such as hot flashes), achiness in the joints a...
D
David Cohen 2 minutes ago
4 How can I tell if my treatment is working “One way you’ll know is if your pain starts going ...
D
The most common side effects are menopausal symptoms (such as hot flashes), achiness in the joints and bones, and fatigue. “AIs can cause some bone loss (osteoporosis), but that can typically be well controlled with bone-modifying medications,” Brufsky notes. CDK4/6 inhibitors may cause low white blood cell counts as well as some nausea and diarrhea.
The most common side effects are menopausal symptoms (such as hot flashes), achiness in the joints and bones, and fatigue. “AIs can cause some bone loss (osteoporosis), but that can typically be well controlled with bone-modifying medications,” Brufsky notes. CDK4/6 inhibitors may cause low white blood cell counts as well as some nausea and diarrhea.
thumb_up Like (22)
comment Reply (0)
thumb_up 22 likes
B
4  How can I tell if my treatment is working 
“One way you’ll know is if your pain starts going away,” Brufsky says. Your doctor will also monitor your progress every few months with a variety of assessments, which may include a physical exam, blood tests to check for tumor markers, and imaging tests: X-ray, CT scan, PET scan, or bone scan.
4 How can I tell if my treatment is working “One way you’ll know is if your pain starts going away,” Brufsky says. Your doctor will also monitor your progress every few months with a variety of assessments, which may include a physical exam, blood tests to check for tumor markers, and imaging tests: X-ray, CT scan, PET scan, or bone scan.
thumb_up Like (15)
comment Reply (0)
thumb_up 15 likes
D
The results of these tests, combined with the symptoms you report, will help your cancer team understand whether your treatment is helping to control tumor growth, according to Breastcancer.org. Treatment is typically continued if it’s working and your side effects are manageable, but if the treatment is no longer working or the side effects are problematic, your doctor may switch you to a different drug. “We expect that just about every treatment we choose will work for a period of time and then likely stop working as the cancer develops resistance,” Brufsky says.
The results of these tests, combined with the symptoms you report, will help your cancer team understand whether your treatment is helping to control tumor growth, according to Breastcancer.org. Treatment is typically continued if it’s working and your side effects are manageable, but if the treatment is no longer working or the side effects are problematic, your doctor may switch you to a different drug. “We expect that just about every treatment we choose will work for a period of time and then likely stop working as the cancer develops resistance,” Brufsky says.
thumb_up Like (5)
comment Reply (1)
thumb_up 5 likes
comment 1 replies
K
Kevin Wang 1 minutes ago
“Fortunately, we have many treatments that are effective with HR-positive/HER-2-negative metastati...
I
“Fortunately, we have many treatments that are effective with HR-positive/HER-2-negative metastatic breast cancer.”
 5  Should I enroll in a clinical trial 
Clinical trials are definitely worth considering, according to the Susan G. Komen organization. They offer the chance to try and possibly benefit from new treatments.
“Fortunately, we have many treatments that are effective with HR-positive/HER-2-negative metastatic breast cancer.” 5 Should I enroll in a clinical trial Clinical trials are definitely worth considering, according to the Susan G. Komen organization. They offer the chance to try and possibly benefit from new treatments.
thumb_up Like (34)
comment Reply (2)
thumb_up 34 likes
comment 2 replies
O
Oliver Taylor 36 minutes ago
The best time to join a trial is before starting treatment or, if your provider is considering chang...
H
Henry Schmidt 71 minutes ago
Komen Metastatic Trial Search, a personalized tool to match you with clinical trials. 6 Will I ever...
B
The best time to join a trial is before starting treatment or, if your provider is considering changing treatments, before you switch to a new treatment. Ask your doctor if there are any trials that would suit your circumstances. You can also search the clinical trial database at ClinicalTrials.gov or use the Susan G.
The best time to join a trial is before starting treatment or, if your provider is considering changing treatments, before you switch to a new treatment. Ask your doctor if there are any trials that would suit your circumstances. You can also search the clinical trial database at ClinicalTrials.gov or use the Susan G.
thumb_up Like (46)
comment Reply (2)
thumb_up 46 likes
comment 2 replies
I
Isabella Johnson 3 minutes ago
Komen Metastatic Trial Search, a personalized tool to match you with clinical trials. 6 Will I ever...
N
Natalie Lopez 2 minutes ago
“We’re not likely going to get rid of every single bit of cancer, but we’re learning that peop...
I
Komen Metastatic Trial Search, a personalized tool to match you with clinical trials. 6  Will I ever be cured 
Oncologists don’t talk about curing stage 4 breast cancer as much as managing it as you would other chronic diseases, according to Brufsky.
Komen Metastatic Trial Search, a personalized tool to match you with clinical trials. 6 Will I ever be cured Oncologists don’t talk about curing stage 4 breast cancer as much as managing it as you would other chronic diseases, according to Brufsky.
thumb_up Like (7)
comment Reply (3)
thumb_up 7 likes
comment 3 replies
M
Mia Anderson 1 minutes ago
“We’re not likely going to get rid of every single bit of cancer, but we’re learning that peop...
J
James Smith 35 minutes ago
The Latest in Breast Cancer How to Avoid Pink Ribbon Pitfalls During Breast Cancer Awareness Month ...
E
“We’re not likely going to get rid of every single bit of cancer, but we’re learning that people can live with this disease and be asymptomatic for years and years,” he explains. “While the mean survival of patients with HR-positive/HER-2-negative metastatic breast cancer is now over five years, it’s hard to say what the future holds for a woman diagnosed with the disease today. The field is changing so quickly and dramatically that in two or three years, this will be a different conversation.”
 Most Recent in Breast Cancer
 What My Mom s Metastatic Breast Cancer Means to Me

 Diagnosed With Breast Cancer  the Third Time Around
 Being Black With Metastatic Breast Cancer   It s a Disadvantage 
 I  Fake It  Til I Make It  — But I m Learning to Ask for HelpNEWSLETTERS
 Sign up for our Cancer Care Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy.
“We’re not likely going to get rid of every single bit of cancer, but we’re learning that people can live with this disease and be asymptomatic for years and years,” he explains. “While the mean survival of patients with HR-positive/HER-2-negative metastatic breast cancer is now over five years, it’s hard to say what the future holds for a woman diagnosed with the disease today. The field is changing so quickly and dramatically that in two or three years, this will be a different conversation.” Most Recent in Breast Cancer What My Mom s Metastatic Breast Cancer Means to Me Diagnosed With Breast Cancer the Third Time Around Being Black With Metastatic Breast Cancer It s a Disadvantage I Fake It Til I Make It — But I m Learning to Ask for HelpNEWSLETTERS Sign up for our Cancer Care Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy.
thumb_up Like (36)
comment Reply (0)
thumb_up 36 likes
H
The Latest in Breast Cancer
 How to Avoid Pink Ribbon Pitfalls During Breast Cancer Awareness Month
Before you donate to a breast cancer organization this month, make sure you know where your money’s going. By Leona VaughnSeptember 30, 2022

 Cancer  Me  and My Solo RaftBy Denise SchipaniSeptember 13, 2022
 Targeted Therapies for Metastatic Breast Cancer— Here&#x27 s What You Should KnowThe latest treatments and therapy approaches for metastatic breast cancer are helping patients live longer and offering new hope.By Cheryl Platzman WeinstockSeptember 7, 2022

 Struggling With Insomnia During Breast Cancer Treatment  Here s How to DealBreast cancer treatment can bring about many sleepless nights. Here’s how to get your sleep schedule back on track.By Carolyn BernhardtSeptember 7, 2022

 Finding Ways to Heal in a Complex Healthcare SystemWhen Theresa Brown, an oncology nurse, was diagnosed with breast cancer in 2017, she found herself on the receiving end of getting care. The experience...By Lambeth HochwaldSeptember 6, 2022

 Navigating Breast Cancer Treatment as a Black WomanWhen Asha Miller was diagnosed with stage 3 breast cancer 4 years ago, she couldn’t find the support she needed as a Black woman going through the experience...By Kaitlin SullivanAugust 24, 2022

 One Woman s Mission to Help African Immigrants Navigate Breast Cancer CareIfy Anne Nwabukwu wants immigrant women in the Washington, DC, area to know that help is just around the corner.By Lambeth HochwaldAugust 24, 2022

 Cutting Into Breast Cancer Disparities With Genetic TestingCancer researcher Olufunmilayo I.
The Latest in Breast Cancer How to Avoid Pink Ribbon Pitfalls During Breast Cancer Awareness Month Before you donate to a breast cancer organization this month, make sure you know where your money’s going. By Leona VaughnSeptember 30, 2022 Cancer Me and My Solo RaftBy Denise SchipaniSeptember 13, 2022 Targeted Therapies for Metastatic Breast Cancer— Here&#x27 s What You Should KnowThe latest treatments and therapy approaches for metastatic breast cancer are helping patients live longer and offering new hope.By Cheryl Platzman WeinstockSeptember 7, 2022 Struggling With Insomnia During Breast Cancer Treatment Here s How to DealBreast cancer treatment can bring about many sleepless nights. Here’s how to get your sleep schedule back on track.By Carolyn BernhardtSeptember 7, 2022 Finding Ways to Heal in a Complex Healthcare SystemWhen Theresa Brown, an oncology nurse, was diagnosed with breast cancer in 2017, she found herself on the receiving end of getting care. The experience...By Lambeth HochwaldSeptember 6, 2022 Navigating Breast Cancer Treatment as a Black WomanWhen Asha Miller was diagnosed with stage 3 breast cancer 4 years ago, she couldn’t find the support she needed as a Black woman going through the experience...By Kaitlin SullivanAugust 24, 2022 One Woman s Mission to Help African Immigrants Navigate Breast Cancer CareIfy Anne Nwabukwu wants immigrant women in the Washington, DC, area to know that help is just around the corner.By Lambeth HochwaldAugust 24, 2022 Cutting Into Breast Cancer Disparities With Genetic TestingCancer researcher Olufunmilayo I.
thumb_up Like (19)
comment Reply (3)
thumb_up 19 likes
comment 3 replies
H
Henry Schmidt 11 minutes ago
Olopade, MD, says, 'In the next decade, I predict we’ll see this kind of optimized treatm...
S
Scarlett Brown 83 minutes ago
 6 Questions About HR-Positive/HER2-Negative Metastatic Breast Cancer — Answered Everyday Heal...
E
Olopade, MD, says, 'In the next decade, I predict we’ll see this kind of optimized treatment become available for everyone...By Susan K. TreimanAugust 24, 2022

 The Long Day  Recovering From My MastectomyBy Denise SchipaniAugust 23, 2022
 Olivia Newton-John  Pop Singer and Star of Grease  Dies at 73Newton-John was first diagnosed with breast cancer in 1992 and later became an advocate for breast cancer survivors.By Don RaufAugust 8, 2022
MORE IN
 What Is Breast Cancer  Symptoms  Causes  Diagnosis  Treatment  and Prevention
 10 Metastatic Breast Cancer Blogs to Read When You Feel Like No One Understands
 Causes of Breast Cancer
Olopade, MD, says, 'In the next decade, I predict we’ll see this kind of optimized treatment become available for everyone...By Susan K. TreimanAugust 24, 2022 The Long Day Recovering From My MastectomyBy Denise SchipaniAugust 23, 2022 Olivia Newton-John Pop Singer and Star of Grease Dies at 73Newton-John was first diagnosed with breast cancer in 1992 and later became an advocate for breast cancer survivors.By Don RaufAugust 8, 2022 MORE IN What Is Breast Cancer Symptoms Causes Diagnosis Treatment and Prevention 10 Metastatic Breast Cancer Blogs to Read When You Feel Like No One Understands Causes of Breast Cancer
thumb_up Like (45)
comment Reply (3)
thumb_up 45 likes
comment 3 replies
A
Amelia Singh 81 minutes ago
 6 Questions About HR-Positive/HER2-Negative Metastatic Breast Cancer — Answered Everyday Heal...
A
Aria Nguyen 89 minutes ago
But a diagnosis of hormone receptor–positive (HR-positive)/human epidermal growth factor receptor ...

Write a Reply